In addition, SLC2A10 expression had no significant correlation with tumor purity but had a significant positive correlation with infiltration levels in head and neck cancer (HNSC), kidney renal papillary cell carcinoma (KIRP), LUAD, LUSC, prostate adenocarcinoma (PRAD) and thyroid carcinoma (THCA) (Fig. 5B, D, F, G, H, J). The gene discussed is SLC2A10; the disease is prostate adenocarcinoma.